FDA approves Shire's Vyvanse for ADHD

02/24/2007 | MSNBC

Shire PLC says the amphetamine-based drug is meant to supplant its top-selling Adderall XR when that drug goes off patent in 2009. Shire says it believes a new formulation, which makes the drug inactive unless swallowed, will curtail potential abuse of the drug.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC